Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease

The accumulation of the uremic toxin indoxyl sulfate (IS) induces target organ damage in chronic kidney disease (CKD) patients, and causes complications including cardiovascular diseases, renal osteodystrophy, muscle wasting, and anemia. IS stimulates reactive oxygen species (ROS) production in CKD,...

Full description

Bibliographic Details
Main Authors: Chien-Lin Lu, Cai-Mei Zheng, Kuo-Cheng Lu, Min-Tser Liao, Kun-Lin Wu, Ming-Chieh Ma
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/6/936
_version_ 1827690150416613376
author Chien-Lin Lu
Cai-Mei Zheng
Kuo-Cheng Lu
Min-Tser Liao
Kun-Lin Wu
Ming-Chieh Ma
author_facet Chien-Lin Lu
Cai-Mei Zheng
Kuo-Cheng Lu
Min-Tser Liao
Kun-Lin Wu
Ming-Chieh Ma
author_sort Chien-Lin Lu
collection DOAJ
description The accumulation of the uremic toxin indoxyl sulfate (IS) induces target organ damage in chronic kidney disease (CKD) patients, and causes complications including cardiovascular diseases, renal osteodystrophy, muscle wasting, and anemia. IS stimulates reactive oxygen species (ROS) production in CKD, which impairs glomerular filtration by a direct cytotoxic effect on the mesangial cells. IS further reduces antioxidant capacity in renal proximal tubular cells and contributes to tubulointerstitial injury. IS-induced ROS formation triggers the switching of vascular smooth muscular cells to the osteoblastic phenotype, which induces cardiovascular risk. Low-turnover bone disease seen in early CKD relies on the inhibitory effects of IS on osteoblast viability and differentiation, and osteoblastic signaling via the parathyroid hormone. Excessive ROS and inflammatory cytokine releases caused by IS directly inhibit myocyte growth in muscle wasting via myokines’ effects. Moreover, IS triggers eryptosis via ROS-mediated oxidative stress, and elevates hepcidin levels in order to prevent iron flux in circulation in renal anemia. Thus, IS-induced oxidative stress underlies the mechanisms in CKD-related complications. This review summarizes the underlying mechanisms of how IS mediates oxidative stress in the pathogenesis of CKD’s complications. Furthermore, we also discuss the potential role of oral AST-120 in attenuating IS-mediated oxidative stress after gastrointestinal adsorption of the IS precursor indole.
first_indexed 2024-03-10T10:34:18Z
format Article
id doaj.art-907486df101f4c71a867b1ae0a428692
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T10:34:18Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-907486df101f4c71a867b1ae0a4286922023-11-21T23:27:13ZengMDPI AGAntioxidants2076-39212021-06-0110693610.3390/antiox10060936Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney DiseaseChien-Lin Lu0Cai-Mei Zheng1Kuo-Cheng Lu2Min-Tser Liao3Kun-Lin Wu4Ming-Chieh Ma5Division of Nephrology, Department of Medicine, Fu Jen Catholic University Hospital, New Taipei 24352, TaiwanDivision of Nephrology, Department of Internal Medicine, College of Medicine, Taipei Medical University, Taipei 11031, TaiwanDivision of Nephrology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 23142, TaiwanDepartment of Pediatrics, Taoyuan Armed Forces General Hospital, Taoyuan 32551, TaiwanDivision of Nephrology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 32551, TaiwanSchool of Medicine, Fu Jen Catholic University, New Taipei 242062, TaiwanThe accumulation of the uremic toxin indoxyl sulfate (IS) induces target organ damage in chronic kidney disease (CKD) patients, and causes complications including cardiovascular diseases, renal osteodystrophy, muscle wasting, and anemia. IS stimulates reactive oxygen species (ROS) production in CKD, which impairs glomerular filtration by a direct cytotoxic effect on the mesangial cells. IS further reduces antioxidant capacity in renal proximal tubular cells and contributes to tubulointerstitial injury. IS-induced ROS formation triggers the switching of vascular smooth muscular cells to the osteoblastic phenotype, which induces cardiovascular risk. Low-turnover bone disease seen in early CKD relies on the inhibitory effects of IS on osteoblast viability and differentiation, and osteoblastic signaling via the parathyroid hormone. Excessive ROS and inflammatory cytokine releases caused by IS directly inhibit myocyte growth in muscle wasting via myokines’ effects. Moreover, IS triggers eryptosis via ROS-mediated oxidative stress, and elevates hepcidin levels in order to prevent iron flux in circulation in renal anemia. Thus, IS-induced oxidative stress underlies the mechanisms in CKD-related complications. This review summarizes the underlying mechanisms of how IS mediates oxidative stress in the pathogenesis of CKD’s complications. Furthermore, we also discuss the potential role of oral AST-120 in attenuating IS-mediated oxidative stress after gastrointestinal adsorption of the IS precursor indole.https://www.mdpi.com/2076-3921/10/6/936AST-120chronic kidney diseaseindoxyl sulfateoxidative stress
spellingShingle Chien-Lin Lu
Cai-Mei Zheng
Kuo-Cheng Lu
Min-Tser Liao
Kun-Lin Wu
Ming-Chieh Ma
Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
Antioxidants
AST-120
chronic kidney disease
indoxyl sulfate
oxidative stress
title Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
title_full Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
title_fullStr Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
title_full_unstemmed Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
title_short Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
title_sort indoxyl sulfate induced redox imbalance in chronic kidney disease
topic AST-120
chronic kidney disease
indoxyl sulfate
oxidative stress
url https://www.mdpi.com/2076-3921/10/6/936
work_keys_str_mv AT chienlinlu indoxylsulfateinducedredoximbalanceinchronickidneydisease
AT caimeizheng indoxylsulfateinducedredoximbalanceinchronickidneydisease
AT kuochenglu indoxylsulfateinducedredoximbalanceinchronickidneydisease
AT mintserliao indoxylsulfateinducedredoximbalanceinchronickidneydisease
AT kunlinwu indoxylsulfateinducedredoximbalanceinchronickidneydisease
AT mingchiehma indoxylsulfateinducedredoximbalanceinchronickidneydisease